Therapeutics

Tools

Back to the Top
Search By Attributes

Search Results

Name Synonyms FDA Status Company Target Type Therapy Type Approved
For
Aduhelm Aducanumab,
BIIB037
Alzheimer's Disease (Approved) Biogen, Neurimmune Amyloid-Related Immunotherapy (passive)
Leqembi Lecanemab-irmb,
BAN2401,
mAb158
Alzheimer's Disease (Approved) BioArctic AB, Biogen, Eisai Co., Ltd. Amyloid-Related Immunotherapy (passive)